William P. Arend

655 total citations
10 papers, 547 citations indexed

About

William P. Arend is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, William P. Arend has authored 10 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in William P. Arend's work include Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (5 papers) and Cell Adhesion Molecules Research (3 papers). William P. Arend is often cited by papers focused on Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (5 papers) and Cell Adhesion Molecules Research (3 papers). William P. Arend collaborates with scholars based in United States and Switzerland. William P. Arend's co-authors include John K. Jenkins, Mark Malyak, Donald Y.M. Leung, Michael F. Smith, David A. Norris, Ralph Berger, Stephen P. Eisenberg, Iris Hart, David Patterson and John Bleskan and has published in prestigious journals such as Immunological Reviews, European Journal of Immunology and Journal of Investigative Dermatology.

In The Last Decade

William P. Arend

10 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William P. Arend United States 9 327 111 94 74 54 10 547
Kurt Schaudt Germany 9 220 0.7× 80 0.7× 104 1.1× 73 1.0× 57 1.1× 14 474
I.L. Eestermans Netherlands 11 310 0.9× 114 1.0× 82 0.9× 102 1.4× 44 0.8× 15 622
Milan Buc Slovakia 15 287 0.9× 114 1.0× 148 1.6× 51 0.7× 71 1.3× 44 671
M Drouet France 16 291 0.9× 178 1.6× 85 0.9× 93 1.3× 57 1.1× 63 915
Katsumi Eguchi Japan 15 283 0.9× 172 1.5× 136 1.4× 46 0.6× 97 1.8× 37 641
P Miossec France 9 420 1.3× 166 1.5× 187 2.0× 120 1.6× 51 0.9× 15 788
P. R. Dunbar United States 12 424 1.3× 111 1.0× 45 0.5× 88 1.2× 99 1.8× 15 755
A Sánchez-Ibarrola Spain 12 280 0.9× 47 0.4× 106 1.1× 58 0.8× 82 1.5× 26 558
Hassan Madani Canada 3 451 1.4× 177 1.6× 146 1.6× 110 1.5× 119 2.2× 3 840
Kenneth J. Pennline United States 12 390 1.2× 113 1.0× 41 0.4× 66 0.9× 58 1.1× 20 775

Countries citing papers authored by William P. Arend

Since Specialization
Citations

This map shows the geographic impact of William P. Arend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Arend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Arend more than expected).

Fields of papers citing papers by William P. Arend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Arend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Arend. The network helps show where William P. Arend may publish in the future.

Co-authorship network of co-authors of William P. Arend

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Arend. A scholar is included among the top collaborators of William P. Arend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Arend. William P. Arend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Palmer, Gaby, et al.. (2003). Mice transgenic for intracellular interleukin‐1 receptor antagonist type 1 are protected from collagen‐induced arthritis. European Journal of Immunology. 33(2). 434–440. 30 indexed citations
2.
Arend, William P.. (2001). The innate immune system in rheumatoid arthritis. Arthritis & Rheumatism. 44(10). 2224–2234. 66 indexed citations
3.
Jenkins, John K., Mark Malyak, & William P. Arend. (1994). The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils.. PubMed. 13(1). 47–54. 149 indexed citations
4.
Arend, William P. & Donald Y.M. Leung. (1994). IgG Induction of IL‐1 Receptor Antagonist Production by Human Monocytes. Immunological Reviews. 139(1). 71–78. 52 indexed citations
5.
Malyak, Mark, et al.. (1994). Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. Journal of Clinical Immunology. 14(1). 20–30. 74 indexed citations
6.
Jenkins, John K. & William P. Arend. (1993). Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1α, IL-3, IL-4 and GM-CSF. Cytokine. 5(5). 407–415. 43 indexed citations
7.
Janson, Robert W, et al.. (1993). Enhanced Production of IL-1 Receptor Antagonist by Alveolar Macrophages from Patients with Interstitial Lung Disease. American Review of Respiratory Disease. 148(2). 495–503. 19 indexed citations
8.
Patterson, David, Iris Hart, John Bleskan, et al.. (1993). The Human Interleukin-1 Receptor Antagonist (IL1RN) Gene Is Located in the Chromosome 2q14 Region. Genomics. 15(1). 173–176. 50 indexed citations
9.
Norris, David A., et al.. (1993). Tumor Necrosis Factor-∝ Induces Interleukin-1∝ and Interleukin-1 Receptor Antagonist Production by Cultured Human Keratinocytes. Journal of Investigative Dermatology. 101(1). 79–85. 61 indexed citations
10.
Arend, William P., et al.. (1985). Stimulation of Production of Interleukin-1 and an Interleukin-1 Inhibitor in Human Monocytes. Lara D. Veeken. XXIV(suppl 1). 175–178. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026